The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery.
Osataphan, Soravis, Rushad Patell, Mrigya Babuta, Rachel P Rosovsky, Yohei Hisada, Charly Edmiston, Pavania Elavalakanar, et al. 2025. “The Efficacy of Rosuvastatin to Reduce Circulating Tissue Factor Extracellular Vesicles After Ovarian Cancer Surgery.”. Blood Advances.